Delivery Order SPE2DB24D2100-SPE2DB25FBEHA
Award Date
5/21/25
Potential Completion Date
6/12/25
Potential Value
$46K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The award does not have a set-aside designation. The potential value of the delivery order is $14,945.14, with a completion date of March 27, 2024. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.18 firm fixed-price delivery order is for VYEPTI 100 MG/ML VIALML, with a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYEPTI 100 MG/ML VIALML pharmaceutical products. The $6,405.06 delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The contract has a completion date of January 25, 2024 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIAL medication. The contract has an ultimate completion date of December 13, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWPH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYEPTI 100 MG/ML vials, a pharmaceutical product, with a ceiling value of $6,943.08. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 29, 2025. The award date is May 7, 2025, and there is no set-aside designation, indicating open...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VYEPTI 100 MG/ML VIALML pharmaceutical products. The firm fixed price contract has a potential value of $9,423.09 and a completion date of January 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $4,270.04 firm fixed price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, with a completion date of February 22, 2024. This award is not designated under any set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $8,528.34 and a final completion date of June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, a delivery order contract worth $35,965.17 for the supply of 400 mg/20 ml vials of the medication VYVGART. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...